Assistant professor Eunhee Yi is exploring how extrachromosomal circular DNA drives cancer progression and drug resistance. Yi’s current research focuses on melanoma, an aggressive form of skin cancer. With support from the Pardee Foundation, her lab is developing a longitudinal model system to track ecDNA formation and perform multi-omics analysis to understand how it drives drug resistance. Additionally, her lab aims to identify drugs that specifically target ecDNA-containing cancer cells.

The 5th Annual Henry Ford + MSU Cancer Research Symposium aims to bring together researchers, clinicians, trainees, and health care professionals from Michigan State University and Henry Ford Health to explore the future of integrated cancer research.

On Sept. 16, Michigan State University received a national honor — the 2025 Golden Goose Award for the scientific success and global impact of cisplatin, the gold standard of cancer-fighting chemotherapy treatments.

Cancer research in the U.S. is backed by a complex system of interdependent funding. Partners include academia, pharmaceutical companies, biotechnology start-ups, federal agencies and private foundations. These groups rely heavily on each other and, when one struggles, the entire system suffers.

People in Flint are concerned about elevated cancer rates, particularly multiple myeloma, and possible links to environmental exposures where they live, work, and play. For many in the community, a lack of high-quality reporting on cancer rates in the wake of the Flint water crisis can be highly distressing, worrisome, and frustrating.

Four dedicated researchers from Michigan State University have received grants totaling more than $3 million from the American Cancer Society, or ACS, to find new ways to prevent, detect, treat and help patients survive colorectal, breast and cervical cancer.